About China Cell Hospital

CHINA CELL Hospital.com is a world-class biomedical institution dedicated to advancing stem cell science, translational medicine, and integrated healthcare. Supported by government investment and strategic joint ventures, the hospital brings together top-tier laboratories, international research collaborations, and multidisciplinary medical centers to provide a comprehensive health management ecosystem.

Cutting-Edge Infrastructure

• GMP-standard stem cell laboratories and biobanks with more than 4,000m² of facilities.

• Joint-venture hospitals and clinical centers for translational medicine and rehabilitation.

• Health Management Center & Sub-Health Prevention Center, focusing on early intervention, genetic testing, and predictive medicine.

• Smart Health & Anti-Aging Programs, integrating modern biotechnology with preventive and lifestyle medicine.

Led by Academician Teams

CHINA CELL is guided by an academician-led expert committee, uniting leading scientists from the Chinese Academy of Sciences, top universities, and international biomedical institutes. With strong expertise in stem cell biology, regenerative medicine, immunology, oncology, and translational science, our team has published numerous high-impact studies and translated them into clinical success stories.

Research and Clinical Focus Areas

1. Metabolic Diseases – Stem cell–based regeneration for Type 1 and Type 2 Diabetes, restoring β-cell function and modulating immunity.

2. Renal Disorders – MSC therapies for Chronic Kidney Disease (CKD), Acute Kidney Injury (AKI), and diabetic nephropathy.

3. Neurological Diseases – Neural stem cells for stroke recovery, Parkinson’s disease, Alzheimer’s disease, and spinal cord injury.

4. Cardiovascular Conditions – Myocardial repair for heart failure and ischemic disease, vascular regeneration for peripheral artery disease.

5. Oncology and Hematology – CAR-T and stem cell transplantation for leukemia, lymphoma, and solid tumors.

6. Autoimmune and Inflammatory Disorders – Stem cell immunoregulation for rheumatoid arthritis, lupus, IBD, and psoriasis.

7. COVID-19 and Pulmonary Disorders – MSC-based therapies successfully applied in clinical rescue cases.

Integrated Medicine Approach

At CHINA CELL, we embrace a holistic healthcare philosophy:

• Combining Western evidence-based medicine, Traditional Chinese Medicine (TCM), and modern biotechnology.

• Building personalized health management programs, including chronic disease management, sub-health intervention, nutrition and lifestyle guidance, psychological counseling, and long-term follow-up.

Success Cases and Impact

• Stem cell therapies applied in COVID-19 rescue, with published SCI papers demonstrating safety and efficacy.

• Clinical programs in diabetes and kidney diseases, achieving improved metabolic and renal outcomes.

• Integrated rehabilitation programs for cancer patients, neurological recovery, and healthy aging.

Our Mission

CHINA CELL Hospital.com is committed to creating a comprehensive life-cycle health management system, combining scientific innovation, government support, and global expertise. Our mission is to transform stem cell research into real-world therapies, bridging science and humanity, and building a healthier future.

👉 To explore more about our research, clinical programs, and health management services, please visit CHINA CELL Hospital.com.

中文介绍

关于 CHINA CELL Hospital.com

CHINA CELL Hospital.com 是一家世界级的生物医学机构，专注于干细胞科学、转化医学与综合健康管理。在 政府重点投资 与 战略合资医院 的支持下，CHINA CELL 汇聚了 顶级实验室、国际科研合作与多学科医疗中心，打造覆盖全生命周期的健康管理生态系统。

顶级科研与医疗平台

• 符合GMP标准的干细胞实验室与细胞库，面积超过4,000平方米。

• 合资医院与临床转化中心，推动科研成果临床落地。

• 健康管理中心与亚健康预防中心，聚焦早筛、基因检测与预测医学。

• 智能健康与抗衰中心，结合现代生物科技与生活方式干预，全面延缓衰老。

院士领衔的专家团队

CHINA CELL 拥有由 两院院士与国际顶尖科学家 组成的核心专家委员会，涵盖干细胞生物学、再生医学、免疫学、肿瘤学与临床转化领域。团队成员在国际高水平期刊发表大量成果，并在临床实践中取得突破性应用。

主要研究与临床方向

1. 代谢性疾病 —— 干细胞再生胰岛β细胞，用于 1型与2型糖尿病 治疗。

2. 肾脏疾病 —— MSC治疗 慢性肾病（CKD）、急性肾损伤（AKI）、糖尿病肾病。

3. 神经系统疾病 —— 神经干细胞用于 脑卒中康复、帕金森病、阿尔茨海默病、脊髓损伤。

4. 心血管疾病 —— 干细胞修复心肌，改善 心衰与缺血性心脏病，促进血管新生。

5. 肿瘤与血液系统疾病 —— CAR-T与干细胞移植 治疗白血病、淋巴瘤与实体瘤。

6. 自身免疫与炎症性疾病 —— 干细胞免疫调控应用于 类风湿关节炎、系统性红斑狼疮、炎症性肠病、银屑病。

7. 新冠与肺部疾病 —— MSC在 新冠重症救治 中已取得成功案例并发表国际SCI论文。

中西医结合的综合方案

CHINA CELL 秉承 “西医循证 + 中医智慧 + 生物科技” 的理念，构建全面的健康管理体系：

• 个性化诊疗方案与慢病管理

• 亚健康预防与功能评估

• 营养、运动与生活方式干预

• 心理辅导与长期随访

成功案例与社会贡献

• 在 新冠疫情救治 中成功应用干细胞疗法，显著改善重症患者预后。

• 糖尿病与肾病临床项目 中，患者代谢与肾功能显著改善。

• 推出 肿瘤康复、神经康复与健康抗衰 综合方案，帮助众多患者重获健康与生活质量。

我们的使命

ChinaCellHospital.com致力于建设一个 科学驱动、政府支持、国际化合作 的生命健康平台，把最前沿的干细胞科研转化为可及疗法，实现 从实验室到床旁的突破，为全球患者创造健康未来。

👉 欢迎访问 CHINA CELL Hospital，了解我们的科研成果、临床项目与健康管理服务。